News

These funds represent the first closing of a Series B venture financing round, the proceeds from which will be used to advance a series of clinical programs and

The partnership will support local and global sponsors looking to bring generic and innovative drugs to the Brazilian market by offering one stop shopping and joint expertise in

AIT-CF is designed to deliver a high dose formulation (160 ppm) to the lungs using positive air pressure and integrated monitoring parameters. The new delivery system has the

Doryx (doxycycline hyclate delayed-release tablets) is a tetracycline-class antimicrobial designed as adjunctive therapy for severe acne. Actavis EVP Commercial, North American Brands William Meury said: "Actavis currently licenses

The NDA requests FDA to approve MorphaBond ER to manage pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.

The new facility is the company’s second plasma center in Jacksonville and has now officially opened for business. The plasma donated at Biotest Plasma Centers is used to

AURION is designed to examine biomarkers of disease activity at eight weeks and their ability to predict response at 24 and 48 weeks. Patient enrolment in this small

The trial’s safety segment is designed to evaluate two doses (60mg/m2 and 90mg/m2) of Liposomal Grb-2 in combination with Ara-C front line therapy, while each dose group will

Around 1,800 patients will be enrolled from across 180 study centres globally in this randomized, double-blind, double-dummy, parallel group multicentre Phase III FULFIL trial. The trial is designed